Table 2 MMR gene mutations in rapid autopsy patients.

From: Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer

Autopsy patient*

Tumour site(s) tested by BROCA targeted sequencing

Mutation burden † (exome)

Hypermutated?

MSI

MMR gene mutation(s) ‡

05–165*

Bone, adrenal, liver and lymph node

855

Yes

Yes

(1) MSH2-C2orf61 343 kb inversion

     

(2) MSH2-KCNK12 74 kb inversion

     

(3) MSH2-KCNK12 40 kb inversion

03–130

Lymph node

647

Yes

Yes

(1) MSH2 translocation splits the gene t(2;18)

     

(2) MSH2 copy loss

     

(3) MSH6 frameshift (c.2690del)

     

(4) MSH6 copy loss

06–134

Kidney and lymph node

314

Yes

Yes

MLH1 homozygous copy loss

00–010

Prostate and liver

673

Yes

Yes

MSH2 frameshift (c.2364_2365insTACA)

05–123

Prostate and lymph node

807

Yes

Yes

(1) MSH2 frameshift (c.1124_1125insG)

     

(2) MSH2 frameshift (c.1082del)

     

(3) MLH1 frameshift (c.1310del), lymph node only

01–095

Liver and lymph node

149

No

No

None

05–144*

Bone, adrenal, liver and lymph node

57

No

No

(1) MSH2 exon 8–16 del

     

(2) MSH6-TESC t(2;12)

05–214

Bone, liver and lymph node (two sites)

46

No

No

None

05–116

Bone, adrenal, liver and lung

47

No

No

None

00–029

Liver

37

No

No

None

00–090

Lymph node

69

No

No

None

  1. MMR, mismatch repair; MSI, microsatellite instability.
  2. *Fifty total unique autopsy patients were assessed by exome sequencing (see Supplementary Table 1). Listed are a subset of cases that were followed up by targeted deep sequencing for MMR genes. Clinical data for this patient subset is provided in Supplementary Table 6. Patient-matched non-cancer tissue was tested in every case and did not exhibit MSI or MMR mutations. LuCaP 147 and 147CR are derived from autopsy patient 05–165. LuCaP 145.1 and 145.2 are derived from autopsy patient 05–144.
  3. †Number of protein altering somatic mutations by exome sequencing with removing of germline variants from matched-non-tumour samples.
  4. ‡Mutations were detected at every tumour site unless otherwise indicated. Mosaic MSH6 frameshift mutations observed in a poly G tract in exon 5 (c.3261dup/del) and poly A tract in exon 7 (c.3573del) were detected in several hypermutated samples and are not included in the table because they are presumed to be due to MSI.